1 Arginase 1 Monoclonal Antibody Market Overview 1.1 Product Overview and Scope of Arginase 1 Monoclonal Antibody 1.2 Arginase 1 Monoclonal Antibody Segment by Type 1.2.1 Global Arginase 1 Monoclonal Antibody Market Value Comparison by Type (2023-2029) 1.2.2 Recombinant 1.2.3 Non-recombinant 1.3 Arginase 1 Monoclonal Antibody Segment by Application 1.3.1 Global Arginase 1 Monoclonal Antibody Market Value by Application: (2023-2029) 1.3.2 Flow Cytometry 1.3.3 ELISA 1.3.4 Western Blot 1.3.5 Immunoprecipitation 1.3.6 Immunofluorescence 1.3.7 Other 1.4 Global Arginase 1 Monoclonal Antibody Market Size Estimates and Forecasts 1.4.1 Global Arginase 1 Monoclonal Antibody Revenue 2018-2029 1.4.2 Global Arginase 1 Monoclonal Antibody Sales 2018-2029 1.4.3 Global Arginase 1 Monoclonal Antibody Market Average Price (2018-2029) 1.5 Assumptions and Limitations 2 Arginase 1 Monoclonal Antibody Market Competition by Manufacturers 2.1 Global Arginase 1 Monoclonal Antibody Sales Market Share by Manufacturers (2018-2023) 2.2 Global Arginase 1 Monoclonal Antibody Revenue Market Share by Manufacturers (2018-2023) 2.3 Global Arginase 1 Monoclonal Antibody Average Price by Manufacturers (2018-2023) 2.4 Global Arginase 1 Monoclonal Antibody Industry Ranking 2021 VS 2022 VS 2023 2.5 Global Key Manufacturers of Arginase 1 Monoclonal Antibody, Manufacturing Sites & Headquarters 2.6 Global Key Manufacturers of Arginase 1 Monoclonal Antibody, Product Type & Application 2.7 Arginase 1 Monoclonal Antibody Market Competitive Situation and Trends 2.7.1 Arginase 1 Monoclonal Antibody Market Concentration Rate 2.7.2 The Global Top 5 and Top 10 Largest Arginase 1 Monoclonal Antibody Players Market Share by Revenue 2.7.3 Global Arginase 1 Monoclonal Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.8 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Arginase 1 Monoclonal Antibody Retrospective Market Scenario by Region 3.1 Global Arginase 1 Monoclonal Antibody Market Size by Region: 2018 Versus 2022 Versus 2029 3.2 Global Arginase 1 Monoclonal Antibody Global Arginase 1 Monoclonal Antibody Sales by Region: 2018-2029 3.2.1 Global Arginase 1 Monoclonal Antibody Sales by Region: 2018-2023 3.2.2 Global Arginase 1 Monoclonal Antibody Sales by Region: 2024-2029 3.3 Global Arginase 1 Monoclonal Antibody Global Arginase 1 Monoclonal Antibody Revenue by Region: 2018-2029 3.3.1 Global Arginase 1 Monoclonal Antibody Revenue by Region: 2018-2023 3.3.2 Global Arginase 1 Monoclonal Antibody Revenue by Region: 2024-2029 3.4 North America Arginase 1 Monoclonal Antibody Market Facts & Figures by Country 3.4.1 North America Arginase 1 Monoclonal Antibody Market Size by Country: 2018 VS 2022 VS 2029 3.4.2 North America Arginase 1 Monoclonal Antibody Sales by Country (2018-2029) 3.4.3 North America Arginase 1 Monoclonal Antibody Revenue by Country (2018-2029) 3.4.4 United States 3.4.5 Canada 3.5 Europe Arginase 1 Monoclonal Antibody Market Facts & Figures by Country 3.5.1 Europe Arginase 1 Monoclonal Antibody Market Size by Country: 2018 VS 2022 VS 2029 3.5.2 Europe Arginase 1 Monoclonal Antibody Sales by Country (2018-2029) 3.5.3 Europe Arginase 1 Monoclonal Antibody Revenue by Country (2018-2029) 3.5.4 Germany 3.5.5 France 3.5.6 U.K. 3.5.7 Italy 3.5.8 Russia 3.6 Asia Pacific Arginase 1 Monoclonal Antibody Market Facts & Figures by Country 3.6.1 Asia Pacific Arginase 1 Monoclonal Antibody Market Size by Country: 2018 VS 2022 VS 2029 3.6.2 Asia Pacific Arginase 1 Monoclonal Antibody Sales by Country (2018-2029) 3.6.3 Asia Pacific Arginase 1 Monoclonal Antibody Revenue by Country (2018-2029) 3.6.4 China 3.6.5 Japan 3.6.6 South Korea 3.6.7 India 3.6.8 Australia 3.6.9 China Taiwan 3.6.10 Southeast Asia 3.7 Latin America Arginase 1 Monoclonal Antibody Market Facts & Figures by Country 3.7.1 Latin America Arginase 1 Monoclonal Antibody Market Size by Country: 2018 VS 2022 VS 2029 3.7.2 Latin America Arginase 1 Monoclonal Antibody Sales by Country (2018-2029) 3.7.3 Latin America Arginase 1 Monoclonal Antibody Revenue by Country (2018-2029) 3.7.4 Mexico 3.7.5 Brazil 3.7.6 Argentina 3.7.7 Colombia 3.8 Middle East and Africa Arginase 1 Monoclonal Antibody Market Facts & Figures by Country 3.8.1 Middle East and Africa Arginase 1 Monoclonal Antibody Market Size by Country: 2018 VS 2022 VS 2029 3.8.2 Middle East and Africa Arginase 1 Monoclonal Antibody Sales by Country (2018-2029) 3.8.3 Middle East and Africa Arginase 1 Monoclonal Antibody Revenue by Country (2018-2029) 3.8.4 Turkey 3.8.5 Saudi Arabia 3.8.6 UAE 4 Segment by Type 4.1 Global Arginase 1 Monoclonal Antibody Sales by Type (2018-2029) 4.1.1 Global Arginase 1 Monoclonal Antibody Sales by Type (2018-2023) 4.1.2 Global Arginase 1 Monoclonal Antibody Sales by Type (2024-2029) 4.1.3 Global Arginase 1 Monoclonal Antibody Sales Market Share by Type (2018-2029) 4.2 Global Arginase 1 Monoclonal Antibody Revenue by Type (2018-2029) 4.2.1 Global Arginase 1 Monoclonal Antibody Revenue by Type (2018-2023) 4.2.2 Global Arginase 1 Monoclonal Antibody Revenue by Type (2024-2029) 4.2.3 Global Arginase 1 Monoclonal Antibody Revenue Market Share by Type (2018-2029) 4.3 Global Arginase 1 Monoclonal Antibody Price by Type (2018-2029) 5 Segment by Application 5.1 Global Arginase 1 Monoclonal Antibody Sales by Application (2018-2029) 5.1.1 Global Arginase 1 Monoclonal Antibody Sales by Application (2018-2023) 5.1.2 Global Arginase 1 Monoclonal Antibody Sales by Application (2024-2029) 5.1.3 Global Arginase 1 Monoclonal Antibody Sales Market Share by Application (2018-2029) 5.2 Global Arginase 1 Monoclonal Antibody Revenue by Application (2018-2029) 5.2.1 Global Arginase 1 Monoclonal Antibody Revenue by Application (2018-2023) 5.2.2 Global Arginase 1 Monoclonal Antibody Revenue by Application (2024-2029) 5.2.3 Global Arginase 1 Monoclonal Antibody Revenue Market Share by Application (2018-2029) 5.3 Global Arginase 1 Monoclonal Antibody Price by Application (2018-2029) 6 Key Companies Profiled 6.1 Sino Biological, Inc. 6.1.1 Sino Biological, Inc. Corporation Information 6.1.2 Sino Biological, Inc. Description and Business Overview 6.1.3 Sino Biological, Inc. Arginase 1 Monoclonal Antibody Sales, Revenue and Gross Margin (2018-2023) 6.1.4 Sino Biological, Inc. Arginase 1 Monoclonal Antibody Product Portfolio 6.1.5 Sino Biological, Inc. Recent Developments/Updates 6.2 ZodelBiotec Ltd. 6.2.1 ZodelBiotec Ltd. Corporation Information 6.2.2 ZodelBiotec Ltd. Description and Business Overview 6.2.3 ZodelBiotec Ltd. Arginase 1 Monoclonal Antibody Sales, Revenue and Gross Margin (2018-2023) 6.2.4 ZodelBiotec Ltd. Arginase 1 Monoclonal Antibody Product Portfolio 6.2.5 ZodelBiotec Ltd. Recent Developments/Updates 6.3 Innovative Research 6.3.1 Innovative Research Corporation Information 6.3.2 Innovative Research Description and Business Overview 6.3.3 Innovative Research Arginase 1 Monoclonal Antibody Sales, Revenue and Gross Margin (2018-2023) 6.3.4 Innovative Research Arginase 1 Monoclonal Antibody Product Portfolio 6.3.5 Innovative Research Recent Developments/Updates 6.4 Geno Technology, Inc. 6.4.1 Geno Technology, Inc. Corporation Information 6.4.2 Geno Technology, Inc. Description and Business Overview 6.4.3 Geno Technology, Inc. Arginase 1 Monoclonal Antibody Sales, Revenue and Gross Margin (2018-2023) 6.4.4 Geno Technology, Inc. Arginase 1 Monoclonal Antibody Product Portfolio 6.4.5 Geno Technology, Inc. Recent Developments/Updates 6.5 CLOUD-CLONE CORP. 6.5.1 CLOUD-CLONE CORP. Corporation Information 6.5.2 CLOUD-CLONE CORP. Description and Business Overview 6.5.3 CLOUD-CLONE CORP. Arginase 1 Monoclonal Antibody Sales, Revenue and Gross Margin (2018-2023) 6.5.4 CLOUD-CLONE CORP. Arginase 1 Monoclonal Antibody Product Portfolio 6.5.5 CLOUD-CLONE CORP. Recent Developments/Updates 6.6 Biomatik 6.6.1 Biomatik Corporation Information 6.6.2 Biomatik Description and Business Overview 6.6.3 Biomatik Arginase 1 Monoclonal Antibody Sales, Revenue and Gross Margin (2018-2023) 6.6.4 Biomatik Arginase 1 Monoclonal Antibody Product Portfolio 6.6.5 Biomatik Recent Developments/Updates 6.7 Assay Genie 6.6.1 Assay Genie Corporation Information 6.6.2 Assay Genie Description and Business Overview 6.6.3 Assay Genie Arginase 1 Monoclonal Antibody Sales, Revenue and Gross Margin (2018-2023) 6.4.4 Assay Genie Arginase 1 Monoclonal Antibody Product Portfolio 6.7.5 Assay Genie Recent Developments/Updates 6.8 Creative Diagnostics 6.8.1 Creative Diagnostics Corporation Information 6.8.2 Creative Diagnostics Description and Business Overview 6.8.3 Creative Diagnostics Arginase 1 Monoclonal Antibody Sales, Revenue and Gross Margin (2018-2023) 6.8.4 Creative Diagnostics Arginase 1 Monoclonal Antibody Product Portfolio 6.8.5 Creative Diagnostics Recent Developments/Updates 6.9 MyBiosource, Inc. 6.9.1 MyBiosource, Inc. Corporation Information 6.9.2 MyBiosource, Inc. Description and Business Overview 6.9.3 MyBiosource, Inc. Arginase 1 Monoclonal Antibody Sales, Revenue and Gross Margin (2018-2023) 6.9.4 MyBiosource, Inc. Arginase 1 Monoclonal Antibody Product Portfolio 6.9.5 MyBiosource, Inc. Recent Developments/Updates 6.10 CUSABIO 6.10.1 CUSABIO Corporation Information 6.10.2 CUSABIO Description and Business Overview 6.10.3 CUSABIO Arginase 1 Monoclonal Antibody Sales, Revenue and Gross Margin (2018-2023) 6.10.4 CUSABIO Arginase 1 Monoclonal Antibody Product Portfolio 6.10.5 CUSABIO Recent Developments/Updates 6.11 Abbexa 6.11.1 Abbexa Corporation Information 6.11.2 Abbexa Arginase 1 Monoclonal Antibody Description and Business Overview 6.11.3 Abbexa Arginase 1 Monoclonal Antibody Sales, Revenue and Gross Margin (2018-2023) 6.11.4 Abbexa Arginase 1 Monoclonal Antibody Product Portfolio 6.11.5 Abbexa Recent Developments/Updates 7 Industry Chain and Sales Channels Analysis 7.1 Arginase 1 Monoclonal Antibody Industry Chain Analysis 7.2 Arginase 1 Monoclonal Antibody Key Raw Materials 7.2.1 Key Raw Materials 7.2.2 Raw Materials Key Suppliers 7.3 Arginase 1 Monoclonal Antibody Production Mode & Process 7.4 Arginase 1 Monoclonal Antibody Sales and Marketing 7.4.1 Arginase 1 Monoclonal Antibody Sales Channels 7.4.2 Arginase 1 Monoclonal Antibody Distributors 7.5 Arginase 1 Monoclonal Antibody Customers 8 Arginase 1 Monoclonal Antibody Market Dynamics 8.1 Arginase 1 Monoclonal Antibody Industry Trends 8.2 Arginase 1 Monoclonal Antibody Market Drivers 8.3 Arginase 1 Monoclonal Antibody Market Challenges 8.4 Arginase 1 Monoclonal Antibody Market Restraints 9 Research Finding and Conclusion 10 Methodology and Data Source 10.1 Methodology/Research Approach 10.1.1 Research Programs/Design 10.1.2 Market Size Estimation 10.1.3 Market Breakdown and Data Triangulation 10.2 Data Source 10.2.1 Secondary Sources 10.2.2 Primary Sources 10.3 Author List 10.4 Disclaimer

List of Tables Table 1. Global Arginase 1 Monoclonal Antibody Market Value Comparison by Type (2023-2029) & (US$ Million) Table 2. Global Arginase 1 Monoclonal Antibody Market Value Comparison by Application (2023-2029) & (US$ Million) Table 3. Global Arginase 1 Monoclonal Antibody Market Competitive Situation by Manufacturers in 2022 Table 4. Global Arginase 1 Monoclonal Antibody Sales (K Units) of Key Manufacturers (2018-2023) Table 5. Global Arginase 1 Monoclonal Antibody Sales Market Share by Manufacturers (2018-2023) Table 6. Global Arginase 1 Monoclonal Antibody Revenue (US$ Million) by Manufacturers (2018-2023) Table 7. Global Arginase 1 Monoclonal Antibody Revenue Share by Manufacturers (2018-2023) Table 8. Global Market Arginase 1 Monoclonal Antibody Average Price (US$/Unit) of Key Manufacturers (2018-2023) Table 9. Global Key Players of Arginase 1 Monoclonal Antibody, Industry Ranking, 2021 VS 2022 VS 2023 Table 10. Global Key Manufacturers of Arginase 1 Monoclonal Antibody, Manufacturing Sites & Headquarters Table 11. Global Key Manufacturers of Arginase 1 Monoclonal Antibody, Product Type & Application Table 12. Global Key Manufacturers of Arginase 1 Monoclonal Antibody, Date of Enter into This Industry Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 14. Global Arginase 1 Monoclonal Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Arginase 1 Monoclonal Antibody as of 2022) Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans Table 16. Global Arginase 1 Monoclonal Antibody Market Size by Region (US$ Million): 2018 VS 2022 VS 2029 Table 17. Global Arginase 1 Monoclonal Antibody Sales by Region (2018-2023) & (K Units) Table 18. Global Arginase 1 Monoclonal Antibody Sales Market Share by Region (2018-2023) Table 19. Global Arginase 1 Monoclonal Antibody Sales by Region (2024-2029) & (K Units) Table 20. Global Arginase 1 Monoclonal Antibody Sales Market Share by Region (2024-2029) Table 21. Global Arginase 1 Monoclonal Antibody Revenue by Region (2018-2023) & (US$ Million) Table 22. Global Arginase 1 Monoclonal Antibody Revenue Market Share by Region (2018-2023) Table 23. Global Arginase 1 Monoclonal Antibody Revenue by Region (2024-2029) & (US$ Million) Table 24. Global Arginase 1 Monoclonal Antibody Revenue Market Share by Region (2024-2029) Table 25. North America Arginase 1 Monoclonal Antibody Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million) Table 26. North America Arginase 1 Monoclonal Antibody Sales by Country (2018-2023) & (K Units) Table 27. North America Arginase 1 Monoclonal Antibody Sales by Country (2024-2029) & (K Units) Table 28. North America Arginase 1 Monoclonal Antibody Revenue by Country (2018-2023) & (US$ Million) Table 29. North America Arginase 1 Monoclonal Antibody Revenue by Country (2024-2029) & (US$ Million) Table 30. Europe Arginase 1 Monoclonal Antibody Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million) Table 31. Europe Arginase 1 Monoclonal Antibody Sales by Country (2018-2023) & (K Units) Table 32. Europe Arginase 1 Monoclonal Antibody Sales by Country (2024-2029) & (K Units) Table 33. Europe Arginase 1 Monoclonal Antibody Revenue by Country (2018-2023) & (US$ Million) Table 34. Europe Arginase 1 Monoclonal Antibody Revenue by Country (2024-2029) & (US$ Million) Table 35. Asia Pacific Arginase 1 Monoclonal Antibody Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million) Table 36. Asia Pacific Arginase 1 Monoclonal Antibody Sales by Region (2018-2023) & (K Units) Table 37. Asia Pacific Arginase 1 Monoclonal Antibody Sales by Region (2024-2029) & (K Units) Table 38. Asia Pacific Arginase 1 Monoclonal Antibody Revenue by Region (2018-2023) & (US$ Million) Table 39. Asia Pacific Arginase 1 Monoclonal Antibody Revenue by Region (2024-2029) & (US$ Million) Table 40. Latin America Arginase 1 Monoclonal Antibody Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million) Table 41. Latin America Arginase 1 Monoclonal Antibody Sales by Country (2018-2023) & (K Units) Table 42. Latin America Arginase 1 Monoclonal Antibody Sales by Country (2024-2029) & (K Units) Table 43. Latin America Arginase 1 Monoclonal Antibody Revenue by Country (2018-2023) & (US$ Million) Table 44. Latin America Arginase 1 Monoclonal Antibody Revenue by Country (2024-2029) & (US$ Million) Table 45. Middle East & Africa Arginase 1 Monoclonal Antibody Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million) Table 46. Middle East & Africa Arginase 1 Monoclonal Antibody Sales by Country (2018-2023) & (K Units) Table 47. Middle East & Africa Arginase 1 Monoclonal Antibody Sales by Country (2024-2029) & (K Units) Table 48. Middle East & Africa Arginase 1 Monoclonal Antibody Revenue by Country (2018-2023) & (US$ Million) Table 49. Middle East & Africa Arginase 1 Monoclonal Antibody Revenue by Country (2024-2029) & (US$ Million) Table 50. Global Arginase 1 Monoclonal Antibody Sales (K Units) by Type (2018-2023) Table 51. Global Arginase 1 Monoclonal Antibody Sales (K Units) by Type (2024-2029) Table 52. Global Arginase 1 Monoclonal Antibody Sales Market Share by Type (2018-2023) Table 53. Global Arginase 1 Monoclonal Antibody Sales Market Share by Type (2024-2029) Table 54. Global Arginase 1 Monoclonal Antibody Revenue (US$ Million) by Type (2018-2023) Table 55. Global Arginase 1 Monoclonal Antibody Revenue (US$ Million) by Type (2024-2029) Table 56. Global Arginase 1 Monoclonal Antibody Revenue Market Share by Type (2018-2023) Table 57. Global Arginase 1 Monoclonal Antibody Revenue Market Share by Type (2024-2029) Table 58. Global Arginase 1 Monoclonal Antibody Price (US$/Unit) by Type (2018-2023) Table 59. Global Arginase 1 Monoclonal Antibody Price (US$/Unit) by Type (2024-2029) Table 60. Global Arginase 1 Monoclonal Antibody Sales (K Units) by Application (2018-2023) Table 61. Global Arginase 1 Monoclonal Antibody Sales (K Units) by Application (2024-2029) Table 62. Global Arginase 1 Monoclonal Antibody Sales Market Share by Application (2018-2023) Table 63. Global Arginase 1 Monoclonal Antibody Sales Market Share by Application (2024-2029) Table 64. Global Arginase 1 Monoclonal Antibody Revenue (US$ Million) by Application (2018-2023) Table 65. Global Arginase 1 Monoclonal Antibody Revenue (US$ Million) by Application (2024-2029) Table 66. Global Arginase 1 Monoclonal Antibody Revenue Market Share by Application (2018-2023) Table 67. Global Arginase 1 Monoclonal Antibody Revenue Market Share by Application (2024-2029) Table 68. Global Arginase 1 Monoclonal Antibody Price (US$/Unit) by Application (2018-2023) Table 69. Global Arginase 1 Monoclonal Antibody Price (US$/Unit) by Application (2024-2029) Table 70. Sino Biological, Inc. Corporation Information Table 71. Sino Biological, Inc. Description and Business Overview Table 72. Sino Biological, Inc. Arginase 1 Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 73. Sino Biological, Inc. Arginase 1 Monoclonal Antibody Product Table 74. Sino Biological, Inc. Recent Developments/Updates Table 75. ZodelBiotec Ltd. Corporation Information Table 76. ZodelBiotec Ltd. Description and Business Overview Table 77. ZodelBiotec Ltd. Arginase 1 Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 78. ZodelBiotec Ltd. Arginase 1 Monoclonal Antibody Product Table 79. ZodelBiotec Ltd. Recent Developments/Updates Table 80. Innovative Research Corporation Information Table 81. Innovative Research Description and Business Overview Table 82. Innovative Research Arginase 1 Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 83. Innovative Research Arginase 1 Monoclonal Antibody Product Table 84. Innovative Research Recent Developments/Updates Table 85. Geno Technology, Inc. Corporation Information Table 86. Geno Technology, Inc. Description and Business Overview Table 87. Geno Technology, Inc. Arginase 1 Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 88. Geno Technology, Inc. Arginase 1 Monoclonal Antibody Product Table 89. Geno Technology, Inc. Recent Developments/Updates Table 90. CLOUD-CLONE CORP. Corporation Information Table 91. CLOUD-CLONE CORP. Description and Business Overview Table 92. CLOUD-CLONE CORP. Arginase 1 Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 93. CLOUD-CLONE CORP. Arginase 1 Monoclonal Antibody Product Table 94. CLOUD-CLONE CORP. Recent Developments/Updates Table 95. Biomatik Corporation Information Table 96. Biomatik Description and Business Overview Table 97. Biomatik Arginase 1 Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 98. Biomatik Arginase 1 Monoclonal Antibody Product Table 99. Biomatik Recent Developments/Updates Table 100. Assay Genie Corporation Information Table 101. Assay Genie Description and Business Overview Table 102. Assay Genie Arginase 1 Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 103. Assay Genie Arginase 1 Monoclonal Antibody Product Table 104. Assay Genie Recent Developments/Updates Table 105. Creative Diagnostics Corporation Information Table 106. Creative Diagnostics Description and Business Overview Table 107. Creative Diagnostics Arginase 1 Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 108. Creative Diagnostics Arginase 1 Monoclonal Antibody Product Table 109. Creative Diagnostics Recent Developments/Updates Table 110. MyBiosource, Inc. Corporation Information Table 111. MyBiosource, Inc. Description and Business Overview Table 112. MyBiosource, Inc. Arginase 1 Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 113. MyBiosource, Inc. Arginase 1 Monoclonal Antibody Product Table 114. MyBiosource, Inc. Recent Developments/Updates Table 115. CUSABIO Corporation Information Table 116. CUSABIO Description and Business Overview Table 117. CUSABIO Arginase 1 Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 118. CUSABIO Arginase 1 Monoclonal Antibody Product Table 119. CUSABIO Recent Developments/Updates Table 120. Abbexa Corporation Information Table 121. Abbexa Description and Business Overview Table 122. Abbexa Arginase 1 Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 123. Abbexa Arginase 1 Monoclonal Antibody Product Table 124. Abbexa Recent Developments/Updates Table 125. Key Raw Materials Lists Table 126. Raw Materials Key Suppliers Lists Table 127. Arginase 1 Monoclonal Antibody Distributors List Table 128. Arginase 1 Monoclonal Antibody Customers List Table 129. Arginase 1 Monoclonal Antibody Market Trends Table 130. Arginase 1 Monoclonal Antibody Market Drivers Table 131. Arginase 1 Monoclonal Antibody Market Challenges Table 132. Arginase 1 Monoclonal Antibody Market Restraints Table 133. Research Programs/Design for This Report Table 134. Key Data Information from Secondary Sources Table 135. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Arginase 1 Monoclonal Antibody Figure 2. Global Arginase 1 Monoclonal Antibody Market Value Comparison by Type (2023-2029) & (US$ Million) Figure 3. Global Arginase 1 Monoclonal Antibody Market Share by Type in 2022 & 2029 Figure 4. Recombinant Product Picture Figure 5. Non-recombinant Product Picture Figure 6. Global Arginase 1 Monoclonal Antibody Market Value Comparison by Application (2023-2029) & (US$ Million) Figure 7. Global Arginase 1 Monoclonal Antibody Market Share by Application in 2022 & 2029 Figure 8. Flow Cytometry Figure 9. ELISA Figure 10. Western Blot Figure 11. Immunoprecipitation Figure 12. Immunofluorescence Figure 13. Other Figure 14. Global Arginase 1 Monoclonal Antibody Revenue, (US$ Million), 2018 VS 2022 VS 2029 Figure 15. Global Arginase 1 Monoclonal Antibody Market Size (2018-2029) & (US$ Million) Figure 16. Global Arginase 1 Monoclonal Antibody Sales (2018-2029) & (K Units) Figure 17. Global Arginase 1 Monoclonal Antibody Average Price (US$/Unit) & (2018-2029) Figure 18. Arginase 1 Monoclonal Antibody Report Years Considered Figure 19. Arginase 1 Monoclonal Antibody Sales Share by Manufacturers in 2022 Figure 20. Global Arginase 1 Monoclonal Antibody Revenue Share by Manufacturers in 2022 Figure 21. The Global 5 and 10 Largest Arginase 1 Monoclonal Antibody Players: Market Share by Revenue in 2022 Figure 22. Arginase 1 Monoclonal Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022 Figure 23. Global Arginase 1 Monoclonal Antibody Market Size by Region (US$ Million): 2018 VS 2022 VS 2029 Figure 24. North America Arginase 1 Monoclonal Antibody Sales Market Share by Country (2018-2029) Figure 25. North America Arginase 1 Monoclonal Antibody Revenue Market Share by Country (2018-2029) Figure 26. United States Arginase 1 Monoclonal Antibody Revenue Growth Rate (2018-2029) & (US$ Million) Figure 27. Canada Arginase 1 Monoclonal Antibody Revenue Growth Rate (2018-2029) & (US$ Million) Figure 28. Europe Arginase 1 Monoclonal Antibody Sales Market Share by Country (2018-2029) Figure 29. Europe Arginase 1 Monoclonal Antibody Revenue Market Share by Country (2018-2029) Figure 30. Germany Arginase 1 Monoclonal Antibody Revenue Growth Rate (2018-2029) & (US$ Million) Figure 31. France Arginase 1 Monoclonal Antibody Revenue Growth Rate (2018-2029) & (US$ Million) Figure 32. U.K. Arginase 1 Monoclonal Antibody Revenue Growth Rate (2018-2029) & (US$ Million) Figure 33. Italy Arginase 1 Monoclonal Antibody Revenue Growth Rate (2018-2029) & (US$ Million) Figure 34. Russia Arginase 1 Monoclonal Antibody Revenue Growth Rate (2018-2029) & (US$ Million) Figure 35. Asia Pacific Arginase 1 Monoclonal Antibody Sales Market Share by Region (2018-2029) Figure 36. Asia Pacific Arginase 1 Monoclonal Antibody Revenue Market Share by Region (2018-2029) Figure 37. China Arginase 1 Monoclonal Antibody Revenue Growth Rate (2018-2029) & (US$ Million) Figure 38. Japan Arginase 1 Monoclonal Antibody Revenue Growth Rate (2018-2029) & (US$ Million) Figure 39. South Korea Arginase 1 Monoclonal Antibody Revenue Growth Rate (2018-2029) & (US$ Million) Figure 40. India Arginase 1 Monoclonal Antibody Revenue Growth Rate (2018-2029) & (US$ Million) Figure 41. Australia Arginase 1 Monoclonal Antibody Revenue Growth Rate (2018-2029) & (US$ Million) Figure 42. China Taiwan Arginase 1 Monoclonal Antibody Revenue Growth Rate (2018-2029) & (US$ Million) Figure 43. Southeast Asia Arginase 1 Monoclonal Antibody Revenue Growth Rate (2018-2029) & (US$ Million) Figure 44. Latin America Arginase 1 Monoclonal Antibody Sales Market Share by Country (2018-2029) Figure 45. Latin America Arginase 1 Monoclonal Antibody Revenue Market Share by Country (2018-2029) Figure 46. Mexico Arginase 1 Monoclonal Antibody Revenue Growth Rate (2018-2029) & (US$ Million) Figure 47. Brazil Arginase 1 Monoclonal Antibody Revenue Growth Rate (2018-2029) & (US$ Million) Figure 48. Argentina Arginase 1 Monoclonal Antibody Revenue Growth Rate (2018-2029) & (US$ Million) Figure 49. Colombia Arginase 1 Monoclonal Antibody Revenue Growth Rate (2018-2029) & (US$ Million) Figure 50. Middle East & Africa Arginase 1 Monoclonal Antibody Sales Market Share by Country (2018-2029) Figure 51. Middle East & Africa Arginase 1 Monoclonal Antibody Revenue Market Share by Country (2018-2029) Figure 52. Turkey Arginase 1 Monoclonal Antibody Revenue Growth Rate (2018-2029) & (US$ Million) Figure 53. Saudi Arabia Arginase 1 Monoclonal Antibody Revenue Growth Rate (2018-2029) & (US$ Million) Figure 54. UAE Arginase 1 Monoclonal Antibody Revenue Growth Rate (2018-2029) & (US$ Million) Figure 55. Global Sales Market Share of Arginase 1 Monoclonal Antibody by Type (2018-2029) Figure 56. Global Revenue Market Share of Arginase 1 Monoclonal Antibody by Type (2018-2029) Figure 57. Global Arginase 1 Monoclonal Antibody Price (US$/Unit) by Type (2018-2029) Figure 58. Global Sales Market Share of Arginase 1 Monoclonal Antibody by Application (2018-2029) Figure 59. Global Revenue Market Share of Arginase 1 Monoclonal Antibody by Application (2018-2029) Figure 60. Global Arginase 1 Monoclonal Antibody Price (US$/Unit) by Application (2018-2029) Figure 61. Arginase 1 Monoclonal Antibody Value Chain Figure 62. Arginase 1 Monoclonal Antibody Production Process Figure 63. Channels of Distribution (Direct Vs Distribution) Figure 64. Distributors Profiles Figure 65. Bottom-up and Top-down Approaches for This Report Figure 66. Data Triangulation Figure 67. Key Executives Interviewed

Sino Biological, Inc. ZodelBiotec Ltd. Innovative Research Geno Technology, Inc. CLOUD-CLONE CORP. Biomatik Assay Genie Creative Diagnostics MyBiosource, Inc. CUSABIO Abbexa